Public relations for life sciences, pharmaceutical, medical devices, diagnostic and healthcare companies

Spindle Communications partners with clients on strategic communications programs – including strategy and brand positioning, corporate communications, as well as public and investor relations to life science, pharmaceutical, medical device and diagnostics and clean and renewable technologies  clients.

At Spindle Comms, our objective is to make our clients better known, better regarded and more successful through effective public relations, marketing communications and investor relations.

We translate the science into stories that resonate with broad audiences by working  with all the parties concerned, being the researchers, patients and with the media. 

From discovery to development to commercialization, Spindle is uniquely able to provide its services to a broad range of life sciences firms. Biotechnology startups are measured and evaluated by more than financial parameters. The right communications strategy and tactical execution can greatly impact how well a young company makes its initial impressions on potential investors, partners, customers, as well as regulatory authorities .

We are dedicated to giving clients in the healthcare and life science industries a clear advantage in a competitive marketplace. Whether placing news stories covering the launch of new research initiatives, investor events, current testing and trials, newsworthy approvals, exciting mergers and aquistions, new funding/investment rounds, confidence-building staff announcements,  profit reports, and also crisis management, generating consistent and positive exposure is essential for ensuring that media effort for the company is well thought and executed.

The benefits:

Gaining investor confidence and appeal as an investment destination for venture capitalists and private equity funders. The duration and the resources required to bring about a product, technology, or service into the market are significant and thus investor fatigue usualy sets in long before the company arrives at the finish line. Sustainable PR/IR can and will reduce the volatility in the perceived risk associated with company and its product/technology

Importantly it may very well allow existing investors to trade in their shareholding of the company in a more liquid market and hence reduce a drop in company.

Last but not least a well structured and executed PR/IR program will allow the company to embark on fund raising at its discretion and make the offering at a higher premium than otherwise would have been the case.
Ultimately life-science public relations is the lifeblood for attaining funding for scientific breakthroughs and profitability.

Spindle Communications focuses on building a company's reputation with the press and industry opinion leaders, establishing credibility and building lasting relationships. Whether introducing a new genetic test, creating awareness of an illness that a healthcare or pharmaceutical company is seeking a new and formidable medicinal arsenal to fight with, proving to consumers and regulatory bodies that a new technology is safe and ethical, or building media mindshare and market acceptance, successful marketing communications practitioners and programs must be able to look near and beyond the horizon.

Much of the company’s present and future may be dependent on clearly defined set of marketing and PR objectives, so is the deployment of these objectives being done proficiently and competitively.

Just as superior science provides the competitive advantage for pharmaceutical and biotech companies, choosing the right life sciences PR agency can be the critical difference between marketing failure and success.

Spindle has perfected the science and art of media relations and orchestrates national and cross-border PR/IR campaigns that achieve objectives such as product and technology visibility, partnership and funding cultivation, clinical trial recruitment, pre-launch market conditioning, new product introductions, reimbursement advocacy, alliance-building and paving the way for successful liquidity event.

Spindle has a track record of working with some of the most innovative companies in the life sciences sector to publicize their science, products and people.

Our focus falls on biotech, pharma, medtech, diagnostics and healthcare public relations, marketing and investor relations services.

For more info, contact Suza Adam on suza.adam@spindlecommunications.com

www.spindlecommunications.com